Bioharvest Sciences Inc. cash flow statement

In fiscal 2025, Bioharvest Sciences Inc.'s operations generated −$7.2m of cash; it spent $2.4m on capital projects, leaving free cash flow of −$9.6m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bioharvest Sciences Inc.: cash flow statement, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	−9	−7	−7
Depreciation and amortisation	1	1	2
Stock-based pay	1	1	—
Capital spending	1	3	2
Free cash flow	−10	−10	−10
Free cash flow after stock pay	−11	−10	—
Shares issued	0	0	18

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BHST vs VYGR BHST vs CCCC BHST vs FHTX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Bioharvest Sciences Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Bioharvest Sciences Inc.